Fluvastatin Sodium
Who holds supplier records for Fluvastatin Sodium? 6 organisations hold a current record for Fluvastatin Sodium: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Netherlands (1), Canada (1) and Greece (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Fluvastatin Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fluvastatin-sodium
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fluvastatin Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Biocon LimitedIndiaCEPActive DMF 36735, 18762, 18493 · latest filing Feb 2022
- TAPI NL BVNetherlandsCEPActive DMF 19296 · latest filing Mar 2006
- DELMAR CHEMICALS INCCanadaActive DMF 18911 · latest filing Oct 2005
- PHARMATHEN INDUSTRIAL SAGreeceActive DMF 24091 · latest filing Aug 2010
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Fluvastatin Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| BIOCON LIMITED Bengaluru | IN | CEP 2022-130 - Rev 02 Fluvastatin sodium, Crystalline-2 | Sept 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2010-201 - Rev 03 Fluvastatin sodium | Mar 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2008-286 - Rev 04 Fluvastatin sodium | Jan 2024 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | R1-CEP 2011-109 - Rev 02 Fluvastatin sodium | Oct 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Fluvastatin Sodium are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- China · Inactive DMF 25992 · filed Apr 2012
- India · Inactive DMF 23657 · filed Apr 2010
- India · Inactive DMF 21509 · filed Mar 2008
- India · Inactive DMF 20528 · filed May 2007
- India · Inactive DMF 17879 · filed Dec 2004
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Fluvastatin Sodium is a synthetic lipid-lowering agent that acts as a competitive inhibitor of HMG-CoA reductase, an enzyme involved in cholesterol biosynthesis. It is primarily used for treating hyperlipidemia and dyslipidemia to prevent cardiovascular diseases.
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- HMG-CoA Reductase Inhibitor
- Mechanism of action
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fluvastatin Sodium?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Fluvastatin Sodium: Biocon Limited (India), TAPI NL BV (Netherlands), DELMAR CHEMICALS INC (Canada), PHARMATHEN INDUSTRIAL SA (Greece), APITORIA PHARMA PRIVATE LTD (India) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fluvastatin Sodium Drug Master Files are active?
Biocon Limited (DMF 36735, 18762), TAPI NL BV (DMF 19296), DELMAR CHEMICALS INC (DMF 18911) and PHARMATHEN INDUSTRIAL SA (DMF 24091). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Fluvastatin Sodium records mean?
5 organisations have only inactive Type II DMFs for Fluvastatin Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Fluvastatin Sodium have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Fluvastatin Sodium on the EDQM register, including BIOCON LIMITED Bengaluru (IN), TAPI NL B.V. Amsterdam (NL), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Fluvastatin Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fluvastatin Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.